Chromatin modification, leukaemia and implications for therapy

British Journal of Haematology

Volumn 118, Issue 3, 2002, Pages 714-727

  Jones, Louise K ^a   Saha, Vaskar ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Chromatin; Leukaemia; Modification; Therapy

Indexed keywords

3 CARBOXYCINNAMIC ACID BISHYDROXAMIDE; CORE BINDING FACTOR; DEPSIPEPTIDE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; MIXED LINEAGE LEUKEMIA PROTEIN; PYROXAMIDE; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; SODIUM PHENYLBUTYRATE; TRANSCRIPTION FACTOR; TRAPOXIN; TRICHOSTATIN A; UNCLASSIFIED DRUG; VORINOSTAT;

APOPTOSIS; B LYMPHOCYTE; CELL CYCLE; CHROMATIN; CHROMOSOME TRANSLOCATION; DNA METHYLATION; DNA MODIFICATION; GENE CONTROL; GENE REPRESSION; HUMAN; LEUKEMIA; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN MODIFICATION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE;

APOPTOSIS; CHROMATIN; DNA METHYLATION; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0036040215     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03586.x     Document Type: Review

References (129)

1. DNA replication progresses on the periphery of nuclear aggregates formed by the BCL6 transcription factor
2. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
3. Retinoic acid-induced apoptosis in leukaemic cells is mediated by paracrine action of tumour-selective death ligand TRAIL
4. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain
5. Towards a minimal motif for artificial transcriptional activators
6. AIB1, a steroid receptor co-activator amplified in breast and ovarian cancer
7. Apoptosis control by death and decoy receptors
8. Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1
9. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
10. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromodomain
11. BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer
12. Fusion genes in leukemia: An emerging network
13. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
14. The activity of mammalian brm/SNF2alpha is dependent on a high-mobility-group protein I/Y-like DNA binding domain
15. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
16. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: Correlation with scaffold attachment regions and topoisomerase II consensus binding sites
17. Solution structure of the interacting domains of the Mad-Sin3 complex: Implications for recruitment of a chromatin-modifying complex
18. Co-repressors 2000
19. Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
20. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
21. A novel fusion between MOZ and the nuclear receptor co-activator TIF2 in acute myeloid leukemia
22. The amino terminus targets the mixed lineage leukemia (MLL) protein to the nucleolus, nuclear matrix and mitotic chromosomal scaffolds
23. Interaction of EVI1 with CBP and P/CAF results in reversible acetylation of EVI1 and in colocalization in nuclear speckles
24. The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase
25. p300/CBP proteins: HATs for transcriptional bridges and scaffolds
26. Co-activation and corepression in transcriptional regulation by steroid/nuclear hormone receptors
27. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA
28. Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: A model for human AML
29. The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1
30. Duality in bromodomain-containing protein complexes
31. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein
32. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF
33. Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene
34. Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily
35. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
36. The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes
37. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein
38. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia
39. Leukemogenesis by CBF oncoproteins
40. Chromatin remodeling enzymes: Who's on first?
41. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer
42. The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3
43. Drosophila ELL is associated with actively elongating RNA polymerase II on transcriptionally active sites in vivo
44. Conjunction dysfunction: CBP/p300 in human disease
45. The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms
46. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia
47. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia
48. Histone acetylation in chromatin structure and transcription
49. Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein
50. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice
51. Interaction of CBF alpha/AML/PEBP2 alpha transcription factors with nucleosomes containing promoter sequences requires flexibility in the translational positioning of the histone octamer and exposure of the CBF alpha site
52. ATP-dependent chromatin remodeling activities
53. Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins
54. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
55. The polycomb protein MPc3 interacts with AF9, an MLL fusion partner in t(9;11)(p22;q23) acute leukemias
56. Notch signalling acts in postmitotic avian myogenic cells to control MyoD activation
57. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF
58. Activation of Gadd34 by diverse apoptotic signals and suppression of its growth inhibitory effects by apoptotic inhibitors
59. The Ikaros gene, a central regulator of lymphoid differentiation, fuses to the BCL6 gene as a result of t(3;7)(q27;p12) translocation in a patient with diffuse large B-cell lymphoma
60. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor
61. The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression
62. P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL
63. Structure and function of a human TAFII250 double bromodomain module
64. Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2 (alpha)) dependent activation of tissue-specific gene transcription
65. SET domain proteins modulate chromatin domains in eu- and heterochromatin
66. PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner
67. Mammalian chromodomain proteins: Their role in genome organisation and expression
68. Cancer epigenetics comes of age
69. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
70. Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis
71. PML-RARalpha alleviates the transcriptional repression mediated by tumor suppressor Rb
72. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes
73. Tip60 acetylates six lysines of a specific class in core histones in vitro
74. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome
75. In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice
76. Histone acetylases and deacetylases in cell proliferation
77. Global role for chromatin remodeling enzymes in mitotic gene expression
78. Gene expression array of HTLV type 1-infected T cells: Up-regulation of transcription factors and cell cycle genes
79. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
80. Proliferation-associated SNF2-like gene (PASG): A SNF2 family member altered in leukemia
81. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors
82. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA
83. A novel mRNA-cDNA interference phenomenon for silencing bcl-2 expression in human LNCaP cells
84. Biochemical analyses of the AF10 protein: The extended LAP/PHD-finger mediates oligomerisation
85. The Drosophila homolog of the human AF10 is an HP1-interacting suppressor of position effect variegation
86. Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A
87. Oncogenic transcription factors in the human acute leukemias
88. Crystal structure of the nucleosome core particle at 2.8 A resolution
89. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia
90. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia
91. Activation of gene expression by small molecule transcription factors
92. Loss of heterozygosity events impeding breast cancer metastasis contain the MTA1 gene
93. Notch as a mediator of cell fate determination in hematopoiesis: Evidence and speculation
94. ATP-dependent nucleosome remodeling and histone hyperacetylation synergistically facilitate transcription of chromatin
95. DNA topoisomerase IIa is required for RNA polymerase II transcription on chromatin templates
96. DNA methylation and chromatin structure affect transcriptional and post-transcriptional transgene silencing in Arabidopsis
97. Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha
98. Chromatin nucleoprotein complexes containing tightly bound c-abl, p53 and bcl-2 gene sequences: Correlation with progression of chronic myelogenous leukemia
99. Rb targets histone H3 methylation and HP1 promoters
100. Sensitization by 5-aza-2′-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1alpha,25-dihydroxyvitamin D3
101. An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells
102. Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13)
103. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability
104. Chromosomal translocations in human cancer
105. Regulation of chromatin structure by site-specific histone H3 methyltransferases
106. Chromatin remodeling and leukemia: New therapeutic paradigms
107. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation
108. DNA methylation in health and disease
109. The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex
110. Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci
111. Translocations, fusion genes, and acute leukemia
112. Targeting histone deacetylase complexes via KRAB-zinc finger proteins: The PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD
113. Somatic gene alteration of AIB1 gene in patients with breast cancer
114. The transcriptional control of hematopoiesis
115. Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes
116. Locking in stable states of gene expression: Transcriptional control during Drosophila development
117. Differential expression and subcellular distribution of the mouse metastasis-associated proteins Mta1 and Mta3
118. The language of covalent histone modifications
119. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: Evidence for direct transcriptional repression of the Rb gene during differentiation
120. ATP-dependent chromatin remodeling factors: Nucleosome shufflers with many missions
121. The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase
122. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex
123. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D3 receptor
124. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
125. Prenatal origin of acute lymphoblastic leukaemia in children
126. The bromodomain: A chromatin-targeting module?
127. Crystal structure of yeast esa1 suggests a unified mechanism for catalysis and substrate binding by histone acetyltransferases
128. Pf1, a novel PHD zinc finger protein that links the TLE corepressor to the mSin3A-histone deacetylase complex
129. HSNF5/INI1 gene mutations in lymphoid malignancy